Advisory · Oncology
The most actively transacted therapeutic area in biopharma.
Ambrosia provides senior-led advisory for oncology licensing, M&A, and strategic partnerships — backed by a proprietary database of 875 verified oncology transactions.
Deal Landscape
What oncology transactions actually look like.
Verified Transactions
875
Median Upfront
$95M
Key Structure Insight
ADC and bispecific deals command 30-40% premiums over small molecule
Selected Work
Oncology·Phase 2 ADC asset — ex-US territorial out-licensing to a top-10 pharma partner
Oncology·Bispecific oncology platform — cross-border M&A execution through close
Related Insights
Research relevant to oncology.
Discuss your oncology transaction.
We’ll meet you at peer level — anywhere in the world.